Clinic
Primary Care Centers of Eastern Kentucky, LLC
Primary Care Centers of Eastern Kentucky, LLC was paid $26.30M by Medicaid between Jan 2018 and Dec 2024, across 188 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 46% of everything it billed.
33Billing provider infoPRIMARY CARE CENTERS OF EASTERN KENTUCKY, LLC
HAZARD, KY 41701
HAZARD, KY 41701
33aNPI1942275805assigned 02/22/2006
33bProvider typeRural Health Clinic/Center
28Total paid$26.30M
24GClaims1,155,733
24DCodes billed188
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in Kentucky
Rank by total paid#2 of 265
Median peer was paid$400K
This provider vs. median66×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 150,711 | $3.55M | |
| 2019 | 145,149 | $3.55M | |
| 2020 | 151,489 | $4.09M | |
| 2021 | 180,004 | $3.81M | |
| 2022 | 177,685 | $3.92M | |
| 2023 | 175,370 | $4.09M | |
| 2024incomplete | 175,325 | $3.28M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 46% | 382,434 | 326,281 | $11.98M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 9.0% | 95,901 | 83,701 | $2.37M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 8.9% | 98,582 | 89,593 | $2.34M |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 7.1% | 138,669 | 130,665 | $1.87M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.2% | 28,471 | 8,424 | $840K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.0% | 11,400 | 3,621 | $527K |
| D0150 | Comprehensive oral evaluation - new or established patient | 1.7% | 12,819 | 12,359 | $443K |
| 99307 | 1.2% | 11,829 | 10,199 | $324K | |
| D7140 | Extraction, erupted tooth or exposed root | 1.2% | 7,475 | 4,015 | $318K |
| D1110 | Prophylaxis - adult | 1.1% | 8,081 | 7,643 | $301K |
| 80053 | Comprehensive metabolic panel | 1.0% | 35,273 | 32,858 | $270K |
| D0330 | Panoramic radiographic image | <1% | 6,751 | 6,465 | $258K |
176 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 44,419 | $256K |
| D1120 | Dental cleaning, child | <1% | 4,689 | $215K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 3,888 | $207K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 6,681 | $198K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,938 | $195K |
| D0274 | Bitewings - four radiographic images | <1% | 8,647 | $192K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 3,037 | $188K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14,426 | $173K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 4,372 | $161K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 9,431 | $158K |
| 99225 | <1% | 4,692 | $143K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 3,126 | $136K |
| 99217 | <1% | 3,433 | $134K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 8,462 | $106K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 7,341 | $103K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,470 | $101K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,548 | $94K |
| 99219 | <1% | 2,178 | $94K | |
| 80061 | Lipid panel | <1% | 10,740 | $92K |
| 76830 | Ultrasound, transvaginal | <1% | 2,509 | $84K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12,107 | $76K |
| 82607 | <1% | 6,483 | $67K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 2,622 | $66K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,974 | $53K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,151 | $47K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 473 | $45K |
| D9110 | <1% | 1,564 | $45K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 121 | $44K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 999 | $43K |
| D0140 | Limited oral evaluation - problem focused | <1% | 888 | $43K |
| D0120 | Dental checkup, returning patient | <1% | 1,447 | $38K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 779 | $35K |
| 99223 | Prolong inpt eval add15 m | <1% | 524 | $33K |
| 0012A | <1% | 1,010 | $32K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 773 | $31K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 642 | $31K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 374 | $28K |
| 99334 | <1% | 580 | $28K | |
| 0011A | <1% | 1,293 | $27K | |
| 84702 | <1% | 2,044 | $26K | |
| 81025 | <1% | 3,469 | $24K | |
| 99490 | Ccm add 20min | <1% | 856 | $23K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,084 | $23K |
| 87807 | <1% | 1,726 | $22K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 378 | $22K |
| D2330 | <1% | 494 | $22K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 27 | $22K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 753 | $22K |
| 90632 | <1% | 473 | $19K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 355 | $18K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 377 | $18K |
| 0001A | <1% | 470 | $17K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 270 | $16K |
| D2331 | <1% | 291 | $16K | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 1,105 | $15K |
| 0002A | <1% | 398 | $15K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 531 | $13K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 179 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,978 | $12K |
| 0064A | <1% | 508 | $11K | |
| 92551 | <1% | 1,140 | $11K | |
| 76801 | <1% | 540 | $11K | |
| 99348 | <1% | 183 | $10K | |
| 90688 | <1% | 1,305 | $10K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,112 | $10K |
| 59025 | Fetal non-stress test | <1% | 324 | $8K |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 1,429 | $8K |
| 86328 | <1% | 556 | $8K | |
| 90686 | <1% | 669 | $7K | |
| 80050 | General health panel | <1% | 261 | $7K |
| 81002 | <1% | 20,010 | $7K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 115 | $6K |
| 83735 | <1% | 1,255 | $6K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 482 | $6K |
| 81001 | <1% | 7,735 | $6K | |
| D0272 | Bitewings - two radiographic images | <1% | 338 | $6K |
| 82728 | <1% | 563 | $5K | |
| 96127 | <1% | 1,979 | $5K | |
| 80305 | <1% | 445 | $5K | |
| 84439 | <1% | 740 | $5K | |
| 82044 | <1% | 1,265 | $5K | |
| 99347 | <1% | 170 | $5K | |
| 83540 | <1% | 1,013 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,490 | $4K |
| 82570 | <1% | 1,266 | $4K | |
| 0072A | <1% | 92 | $3K | |
| 90670 | <1% | 1,971 | $3K | |
| 0071A | <1% | 82 | $3K | |
| 99050 | <1% | 373 | $3K | |
| 11721 | <1% | 77 | $3K | |
| 87210 | <1% | 628 | $3K | |
| 0004A | <1% | 105 | $3K | |
| 90633 | <1% | 2,812 | $3K | |
| 99173 | <1% | 257 | $3K | |
| D2332 | <1% | 46 | $2K | |
| 99304 | <1% | 83 | $2K | |
| 84481 | <1% | 216 | $2K | |
| 82951 | <1% | 207 | $2K | |
| 76818 | <1% | 86 | $2K | |
| 74018 | <1% | 180 | $2K | |
| 83550 | <1% | 275 | $2K | |
| 72100 | <1% | 119 | $2K | |
| 93000 | <1% | 89 | $1K | |
| 90671 | <1% | 319 | $1K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 138 | $1K |
| 90715 | <1% | 160 | $1K | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 19 | $1K |
| 90680 | <1% | 951 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 518 | $1K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 28 | $1K |
| 90723 | <1% | 401 | $931.30 | |
| 97597 | <1% | 29 | $912.21 | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | <1% | 65 | $892.05 |
| 90651 | <1% | 166 | $760.80 | |
| 0134A | <1% | 25 | $760.00 | |
| 99381 | <1% | 13 | $707.28 | |
| 90732 | <1% | 14 | $700.00 | |
| 90647 | <1% | 956 | $572.01 | |
| 73630 | <1% | 33 | $456.48 | |
| 76642 | <1% | 12 | $443.89 | |
| 0003A | <1% | 22 | $440.00 | |
| 83880 | <1% | 37 | $396.00 | |
| 90685 | <1% | 74 | $382.29 | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 12 | $348.23 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 67 | $330.43 |
| 90619 | <1% | 123 | $321.50 | |
| 99335 | <1% | 12 | $312.00 | |
| 90710 | <1% | 74 | $297.57 | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 25 | $240.97 |
| 90697 | <1% | 340 | $232.77 | |
| 83001 | <1% | 12 | $216.08 | |
| 99406 | <1% | 38 | $208.43 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15 | $202.80 |
| 90734 | <1% | 140 | $198.46 | |
| 90700 | <1% | 228 | $198.25 | |
| 86580 | <1% | 50 | $166.79 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 15 | $166.77 |
| 84100 | <1% | 53 | $166.34 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 13 | $155.82 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 65 | $142.09 |
| 90707 | <1% | 14 | $98.25 | |
| 3074F | <1% | 17,482 | $93.37 | |
| 3078F | <1% | 14,980 | $77.92 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 89 | $60.00 |
| 85014 | <1% | 29 | $56.88 | |
| 85018 | <1% | 29 | $56.88 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 14 | $45.54 |
| J3490 | Unclassified drugs | <1% | 13 | $41.13 |
| 3079F | <1% | 6,560 | $39.90 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 51 | $39.55 |
| 90713 | <1% | 13 | $27.44 | |
| 3044F | <1% | 4,408 | $21.88 | |
| 3075F | <1% | 2,480 | $14.95 | |
| 3077F | <1% | 1,847 | $10.81 | |
| 3046F | <1% | 449 | $2.06 | |
| 3080F | <1% | 287 | $1.71 | |
| 3045F | <1% | 381 | $1.13 | |
| H0049 | Alcohol and/or drug screening | <1% | 74 | $1.00 |
| 2022F | <1% | 233 | $0.96 | |
| 3051F | <1% | 27 | $0.09 | |
| 3052F | <1% | 18 | $0.06 | |
| 2028F | <1% | 639 | $0.02 | |
| 90750 | <1% | 15 | $0.01 | |
| 4004F | 0% | 52 | $0.00 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 0% | 150 | $0.00 |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | 0% | 48 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 14 | $0.00 |
| 888888 | 0% | 12 | $0.00 | |
| 1111F | 0% | 136 | $0.00 | |
| 4000F | 0% | 52 | $0.00 | |
| 3008F | 0% | 362 | $0.00 | |
| 90716 | 0% | 15 | $0.00 | |
| 91307 | 0% | 35 | $0.00 | |
| 90696 | 0% | 27 | $0.00 | |
| 90381 | 0% | 12 | $0.00 | |
| 91306 | 0% | 59 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARTIN, BARRY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Beacons of Hope, LLC | Hazard, KY | $6.58M |
| Primary Care Centers of Eastern Kentucky, LLC | Scuddy, KY | $3.64M |
| Primary Care Centers of Eastern Kentucky, LLC | Hindman, KY | $1.81M |
| Primary Care Centers of Eastern Kentucky, LLC | Hyden, KY | $1.52M |
| Homecare Advantage,llc | Terre Haute, IN | $57K |
| Mary E Martin Diabetes Center of Excellence, INC | Hazard, KY | $16K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.